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LC-MS/MSa b s t r a c t
Introduction: Burn injury inevitably leads to changes in the endogenous production of cytokines, as well
as adrenal and gonadal steroids. Previous studies have reported gender-related differences in outcome
following burn injury, which suggests that gonadal steroids may play a role. The aim of this study was
to assess alterations in concentration of endogenous steroids in patients with burn injury.
Methods: For this single-center, prospective descriptive study, high-sensitivity liquid chromatography
tandem mass spectrometry (LC-MS/MS)-based steroid quantification was used to determine longitudinal
profiles of the concentrations of endogenous steroids in plasma from sixteen adult male patients with
burn injury (14.5–72% of total body surface area). Steroids were extracted from plasma samples and ana-
lyzed using multiple reaction monitoring acquisition, with electrospray ionization on a triple quadruple
mass spectrometer. Total protein concentration was measured in the samples using spectrophotometry.
Results: Steroid and total protein concentration distributions were compared to reference intervals char-
acteristic of healthy adult men. Concentrations of the following steroids in plasma of burn injured
patients were found to correlate positively to the area of the burn injury: cortisol (r = 0.84), corticosterone
(r = 0.73), 11-deoxycortisol (r = 0.72), androstenedione (r = 0.72), 17OH-progesterone (r = 0.68), 17OH-
pregnenolone (r = 0.64) and pregnenolone (r = 0.77). Concentrations of testosterone decreased during
the acute phase and were up to ten-times lower than reference values for healthy adult men, while con-
centrations of estrone were elevated. By day 21 after injury, testosterone concentrations were increased
in younger, but not older, patients. The highest concentrations of estrone were observed on day 3 after
the injury and then declined by day 21 to concentrations comparable to those observed on the day of
the injury.
Conclusion: Burn injury alters endogenous steroid biosynthesis, with decreased testosterone concentra-
tions and elevated estrone concentrations, during the first 21 days after the injury. Concentrations of
glucocorticoids, progestagens and androgen precursors correlated positively with the area of burn injury.
The finding of increased estrone following burn injury needs to be confirmed in a larger hypothesis-
driven study.
 2016 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by
Elsevier B.V. This is an open access article under the CCBY license (http://creativecommons.org/licenses/by/
4.0/).1. Introduction
Severe burn injury is associated with high mortality and multi-
ple organ failure [1]. The stress factors after burn injury are many
and continuous. Large open wounds, dressing changes, mechanical
20 M. Bergquist et al. / Clinical Mass Spectrometry 1 (2016) 19–26ventilation, surgery and infection may all cause severe inflamma-
tion. In addition, a hypermetabolic state may follow with increased
metabolic rate, peripheral insulin resistance, extensive protein
wasting, lean body mass loss, and bone and muscle catabolism,
often complicated with functional and structural alterations of
essential organs [2–4]. The altered homeostasis after burn injury
inevitably leads to changes in the circulating levels of cytokines,
glucagon, catecholamines, and adrenal and gonadal steroids [5,6].
Marked perturbations in HPA axis and elevated cortisol concentra-
tions have also been observed in major burn injury [7–11]. More-
over, gender-specific differences in mortality following burn
injury have been previously reported [12,13]. Among burn trauma
patients, premenopausal women have a survival advantage, as
compared to men and postmenopausal women [14,15]. In addition,
gender and age differences have been documented in concentra-
tions of circulating cytokine and multiple organ dysfunction
syndrome (MODS), following polytrauma [16]. Physiologic concen-
trations of estrogens under normal conditions were suggested to
be immune-stimulatory, while testosterone is thought to suppress
immunity [17,18]. Hypotestosteronemia, defined as total serum
testosterone < 2.5 ng/mL [19], was commonly observed in critically
ill men [20–22].
Previous studies have demonstrated differences in concentra-
tions of gonadal steroids in burn patients, but have focused only
on estradiol and testosterone, and have not examined the
upstream intermediates and precursors of the steroid biosynthesis
pathway, (e.g., estrone, androstenedione, DHEA, pregnenolone,
17OH-pregnenolone and 17OH-progesterone). Commercially avail-
able immunoassays were shown to be unreliable for quantification
of testosterone when endogenous concentrations are expected to
be low [23].
This study is a single-center, prospective descriptive study of
male adult patients with burn injury with the aim of assessing
changes in the biosynthesis of adrenal and gonadal steroids during
the acute (0–3 days) and the sub-acute (7–21 days) phases follow-
ing burn injury. To our knowledge, this is the first report to assess
concentration variability for a panel of endogenous steroids in
patientswithburn injury, usinghigh sensitivity LC-MS/MSmethods.2. Materials and methods
2.1. Patients
The study was approved by the Ethical Committee for Human
Research in Uppsala, Sweden
(Dnr 2011/484). Patients were recruited between March 2012
and March 2013 from a larger study cohort in the Burn Center
(BC) of Uppsala University Hospital, Sweden. Informed consent
was obtained via next of kin and directly from survivors as soon
as possible. Adult patients (>18 years) were eligible regardless of
burn injury type. Exclusion criteria were malignancy, immune
deficiency (HIV, cytostatic drugs, corticosteroids, tetracyclines or
certain bisphosphonates), known or suspected blood-transmitted
infections and participation in another clinical study within the
last 4 weeks. Patients were partitioned into two subgroups based
on burn size: severely injured (>20% burned of the total body sur-
face area (TBSA)) and moderately injured (<20% TBSA burned) [24].
To limit confounding factors in the study, only samples from adult
men were included. Sepsis was considered present based on crite-
ria from the American Burn Association [25]: laboratory signs of
infection (e.g., reduced platelets (not caused by bleeding),
increased or reduced leucocytes, increased CRP and procalcitonin
(PCT)), clinical signs of infection (e.g., body temperature >39 or
<36.5 C, signs of pneumonia, obvious wound infections), and
positive bacterial cultures from blood, wounds or airways. Signsof newly developed circulatory instability were also included in
the sepsis assessment, such as reduced blood pressure, increasing
lactate levels and need for intravenous fluid and vasoactive
support.
Daily monitoring of the degree of organ dysfunction (serum
albumin levels, bilirubin and creatinine levels, platelet count,
Glasgow Coma Scale score, maximal vasoactive/inotrope dose,
and lowest PaO2/FiO2) were registered and Sequential Organ Fail-
ure Assessment (SOFA-score) was determined on every sampling
day. Other laboratory tests (e.g., CRP, procalcitonin, leukocyte
count, and microbiological cultures) were performed as clinically
needed. Patients’ weight and daily cumulative fluid balance were
determined on each day of sampling. Outcome (28 day and
3 month mortality) was registered for each patient.
2.2. Sample collection
Blood samples for analysis of steroids were collected from
arterial line/venipuncture upon admission and in intervals there-
after at 1, 3, 7, 14 and 21 days after admission. Blood samples were
centrifuged at 2000g for 10 min, plasma was separated and stored
at 70 C until analysis.
2.3. Steroids analysis
Five classes of steroids were measured in plasma samples using
LC-MS/MS: glucocorticoids (cortisol, cortisone, corticosterone,
11-deoxycortisol); androgens (dehydroepiandrosterone (DHEA),
androstenedione, testosterone); pregnanes (pregnenolone, 17-OH
pregnenolone); estrogens (estrone and estradiol); and progestins
(17-OH progesterone, progesterone).
Testosterone (Te), estrone (E1), estradiol (E2), pregnenolone
(Pregn), cortisol, cortisone, 17-hydroxypregnenolone (17OHPregn),
17-hydroxyprogesterone (17OHP), formic acid, hydroxylamine,
trifluoroacetic acid, sodium carbonate and dansyl chloride were
purchased from Sigma Chemical Company (St Louis, MO, USA).
Androstenedione (A4), dehydroepiandrosterone (DHEA) and
progesterone (PROG) were purchased from Steraloids Inc. (New-
port, RI, USA). Deuterium labeled analogues of the steroids
d3-testosterone, d3-pregnenolone, d2-11-deoxycortisol, d9-17-OH
progesterone, d3-17OH pregnenolone, d4-cortisol, d3-cortisone,
(purchased from Cambridge Isotope Laboratories, Andover, MA,
USA), and d4-estrone and d3-estradiol, (purchased from CDN
Isotopes, Toronto, ON, Canada) were used as internal standards.
Calibration standards were prepared using standards purchased
from Cerilliant (Round Rock, TX, USA). All other chemicals were of
the highest purity commercially available.
Samples were analyzed as previously described [26–29]. In
short, steroids were extracted from 100 lL of plasma aliquots; cor-
tisol and corticosterone were analyzed as described in [30]; DHEA,
A4, Te, Pregn, 17OHPregn, 17OHP and progesterone (P4) were
derivatized with hydroxylamine to form oxime derivatives;
estrone and estradiol were derivatized with dansyl chloride to
form dansyl derivatives [27]. Limits of quantification (LOQ) are
presented in Table 1 [28]. The intra-assay and inter-assay CVs were
<8% and <11%, respectively [26–28]. All steroids were analyzed in
positive ion mode using an electrospray ion source on a triple
quadruple mass spectrometer (AB Sciex 5500; Foster City, CA,
USA). The HPLC system consisted of series 1260 and 1290 HPLC
pumps (Agilent Technologies, Santa Clara, CA, USA), and an HTC
PAL autosampler (LEAP Technologies, NC, USA) equipped with a
fast wash station. Two mass transitions were monitored for each
steroid and its internal standard (IS). Quantitative data analysis
was performed using Analyst 1.5.2 software. Calibration curves
were generated with every set of samples using six calibrators.
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evaluated by comparing concentrations determined using the pri-
mary and the secondary mass transitions of each steroid and its
internal standard [31].
2.4. Protein assay
Total protein concentration in the samples was determined
using a NanoDropTM 8000 spectrophotometer (Thermo Scientific,
Wilmington, DE, USA) [32]. The optical path of the spectropho-
tometer was blanked, then 2 lL aliquots of each sample were
loaded on optical pedestals of the instrument and total protein
concentration determined using direct absorbance measurements
at 280 nm. Bovine serum albumin QC samples, prepared at concen-
trations of 20 and 80 mg/mL and analyzed in duplicate, were ana-
lyzed along with the patient samples. In addition, ten samples out
of the set were analyzed in duplicate. The imprecision of repeat
measurements was <5%.
2.5. Statistical analysis
Descriptive data are presented as boxplots and whiskers (min
and max) (Figs. 1–3 and S1), or as means and standard deviationFig. 1. Glucocorticoid concentrations in severely and moderately burn-injured patients f
intervals for healthy male adults. TBSA; total body surface area.(Fig. S2). As the results for several of the measured steroids were
non-normally distributed using the D’Agostino-Pearson omnibus
normality test, correlations of the concentrations of steroids with
burn size were assessed using the Spearman correlation test.
Differences in concentration of steroids between survivors and
non-survivors on day 1 after injury were as tested using a two-
tailed Mann–Whitney test. p values < 0.05 were considered
statistically significant. Statistical analysis was performed using
Graphpad Prism v6.05 for Windows (Graphpad Software Inc., La
Jolla, CA, USA)
3. Results
In this descriptive study we quantified adrenal and gonadal
steroids in plasma from male adult patients with burn injury.
Patient demographics are presented in Table 2. The median (range)
burn surface in the sixteen patients was 32% (15–72%) of TBSA.
There was no statistically significant difference in total protein or
serum albumin concentrations between the severely and moder-
ately injured (Fig. S1). The median values of the total protein and
serum albumin concentration were outside of the reference inter-
vals for healthy adults (dotted and dashed lines, Fig. S1); concen-
trations of total protein were the lowest on days 0–3 after the
injury and increased during the recovery, while serum albumin
concentrations remained below the reference intervals characteris-
tic of healthy adults until day 21 following the injury. Over time,
while the concentration of albumin tended to decrease after burn
injury, the concentration of total protein tended to increase. As
no significant difference was observed in adrenal and gonadal ster-
oids between the severely and moderately injured patients, plasma
steroid levels are presented as one group throughout the study.
3.1. Glucocorticoids
In most patients with burn injury, concentrations of cortisol,
corticosterone and 11-deoxycortisol were highest upon admission
to the burn center (Fig. 1). Maximum concentrations of cortisone
were observed on day 21 after burn injury in several patients. Upon
admission, concentrations of corticosterone and 11-deoxycortisolrom admission to day 21 quantified by LC-MS/MS. Dotted lines represent reference
Fig. 2. Sex steroid concentrations in severely and moderately burn-injured patients from admission to day 21 quantified by LC-MS/MS. Dotted lines represent reference
intervals for healthy male adults. TBSA; total body surface area.
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patients (0.60–8.20 ng/mL and <0.5 ng/mL, respectively). Concen-
trations of cortisol, corticosterone and 11-deoxycortisol were
found to correlate with the area of burn injury (Fig. 4). Concentra-
tions of cortisone were higher in non-survivors compared to sur-
vivors on day 1 after the injury (Fig. S2, p = 0.006).3.2. Sex steroids
In all patients, the median concentrations of testosterone,
androstenedione and DHEA were highest upon admission to the
burn center (Fig. 2). The testosterone concentrations decreased
during the acute phase and were up to ten times lower than the
reference values expected in healthy adult men (3.0–10.8 ng/mL)
[29]; the concentrations did not recover during the study period
(Fig. 2). At the end of the study period, testosterone concentrations
increased in patients of younger age (<50 years, Fig. S3), while
remaining below the values characteristic of healthy adult men.
Patients of older age (>50 years) did not display an increase in
testosterone concentration during the study period. Concentra-
tions of estradiol were below the reference intervals expected of
healthy adult men (10–42 pg/mL) [28] between day 7 after injury
until the end of the study period. In contrast, patients displayed
elevated concentrations of estrone, with values above the referenceintervals characteristic of healthy adult men (9–36 pg/mL [28],
Fig. 2). During the study period, concentrations of estrone did not
retrocede to the values expected of healthy men. Contrary to the
other steroids, the highest concentrations of estrone were observed
on day 3 after injury and then declined by day 21 to concentrations
comparable to those observed on the day of the injury. In most of
the patients, concentrations of estradiol were the highest on day 3
after injury. Concentrations of testosterone and estradiol did not
correlate with the size of the injury, while estrone displayed a
nearly significant correlation with the area of burn injury
(r = 0.490, p = 0.065, data not shown). Concentrations of
androstenedione and DHEA were higher in the non-survivors com-
pared to survivors on day 1 after the injury (Fig. S2, p = 0.011 and
0.006, respectively).3.3. Progestagens
In patients with burn injury, concentrations of pregnenolone,
17OH-pregnenolone and 17OH-progesterone were the highest
upon admission to the burn center (Fig. 3). Upon admission,
concentrations of 17OH-pregnenolone were above the reference
values for healthy adult men (<4.42 ng/mL). In contrast, 21 days
after injury, patients displayed median concentrations of
pregnenolone below the reference values for healthy adult men
Fig. 3. Progestagen concentrations in severely and moderately burn-injured patients from admission to day 21 quantified by LC-MS/MS. Dotted lines represent reference
intervals for healthy male adults. TBSA; total body surface area.
Table 2
Demographics of study patients.
Burn > 20% TBSA (n = 12) Burn < 20% TBSA (n = 4) p-Value
Age in years, median (range) 60 (18–69) 49 (20–75) 0.61
Body mass index, median (range) 25.0 (20.5–27.8) 25.0 (23.8–28.6) 0.41
Inhalation injury 6/12 3/4 0.42
Ventilator treated 9/12 3/4 1.0
Sepsis at any time during study period 8/12 1/4 0.17
Heart disease 3/12 2/4 0.38
Abuse 2/12 0/4 0.48
Hours from injury to first sample, median (range) 5 (2–14) 7 (6–10) 0.39
Survival 21 days 10/12 3/4 0.73
Survival 3 months 10/12 3/4 0.73
TBSA, total body surface area.
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pregnenolone and 17OH-progesterone were found to correlate to
the area of burn injury (Fig. 4). Concentrations of pregnenolone,
17OH-pregnenolone and 17OH-progesterone were higher in the
non-survivors compared to survivors on day 1 after injury
(Fig. S2, p = 0.036, 0.019 and 0.008, respectively).4. Discussion
Burn injury causes an extreme increase in metabolic rate and
energy requirements, with the changes affecting the rate of the
biosynthesis of endogenous steroids [6]. In this study we observed
that concentrations of cortisol, corticosterone, 11-deoxycortisol,
androstenedione, pregnenolone, 17OH-pregnenolone, and 17OH-
progesterone were associated with the size of burn injury in male
patients, suggesting that concentrations of circulating endogenous
adrenal and gonadal steroids are affected by burn injury. In detail,
we observed that cortisol plasma levels correlated positively with
the burn injury size, despite being within the reference intervals
in most patients.
Elevated concentrations of plasma cortisol are known to be a
hallmark of critical illness [33,34], and inappropriately lowconcentrations of cortisol have previously been linked to an
increased mortality [35]. It is well known that burn injury disturbs
the circadian rhythm and diurnal pattern of circulating plasma cor-
tisol [8,36,37]. The release of cortisol and DHEA are both responses
to the level of adrenocorticotrophic hormone (ACTH), and are both
potent modulators of the immune response. Our results, which
demonstrate a combination of elevated concentrations of cortisol
and decreased concentrations of DHEA, are in agreement with pre-
viously reported findings following thermal injury [7,38]. In the
present study, we observed increased concentrations of estrogens
and decreased concentrations of androgens, which have also been
observed in other severe conditions, such as sepsis, shock and
myocardial infarction [39–42].
In patients with burn injury, low concentrations of testosterone
have been associated with osteoporosis, loss of lean body mass and
impaired wound healing [43]. As testosterone is the main endoge-
nous anabolic steroid, hypotestosteronemia following critical
illness may have severe ramifications for the patient, such as
decreased lean body mass, muscle function impairment and exer-
cise intolerance [44]. Thus, hypotestosteronemia in burn-injured
patients may increase the risk of delayed ventilator weaning and
physical recovery, although we did not investigate these parame-
ters in this study. Furthermore, testosterone has been shown to
Fig. 4. Scatter plots representing associations between endogenous steroid concentrations and area of burn injury in all patients at admission. Correlations were analyzed
using Spearman correlation test.
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increasing the susceptibility to sepsis and even worsening the out-
come after sepsis [45,46].
Low concentrations of circulating testosterone following burn
injury may potentially be caused by several factors, such as down-
regulated hypothalamic-pituitary–gonadal (HPG) axis, effect of
cytokines on Leydig cells, and increased peripheral aromatase
activity. Aromatase is required for biosynthesis of estrone and
estradiol and is present in several tissues, such as skin, bone, adi-
pose tissue, arteries and brain [47]. Increased aromatase activity
following burn injury likely contributes to the elevated concentra-
tions of estrone observed in patients in this study (Fig. 5). Elevated
concentrations of estrone have previously been correlated withseverity and outcome in septic shock [48]. Estrone has also been
shown to be neuroprotective in rats following traumatic brain
injury (TBI) and may stimulate neurogenesis [49]. The increased
levels of estrone observed in this study and increased tolerance
to a burn injury, could be explained in part to arrested conversion
of androstenedione to testosterone by 17b-hydroxysteroid
hydrogenase (17b-HSD), in favor of estrone biosynthesis by action
of aromatase (Fig. 5).
Recently, it was shown that estradiol administration in rats fol-
lowing scald burn had a protective effect by attenuating the hyper-
metabolic state [50], while testosterone depletion by castration
was shown to protect mice from heat-induced multi-organ damage
and lethality [51]. Moreover, high testosterone concentrations may
Fig. 5. Schematic overview of the steroid pathway. The obtained results in this study suggest a general reduction of the 17b-HSD enzymatic pathway resulting in decreased
concentrations of androstenedione, testosterone and estradiol, and increased activity of aromatase, leading to increased concentrations of estrone.
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cell-mediated immunity and cytokine expression [52], which
further supports the theory that the increased levels of estrone
observed in patients in the present study, could have a survival
benefit in burn injury. Inhibition of 17b-HSD and/or activation of
aromatase, leading to a shift from androgen to estrogen hormonal
responses, in turn would conserve energy for essential metabolism
and wound healing instead of building muscles and bone.
An increased plasma estrone concentration is likely to reflect a
transiently elevated peripheral aromatization in adipose tissue,
associated with the burn injury. This is further supported by alter-
ations in adipose tissue observed in response to critical illness,
such as increased number of adipocytes [53]. In addition, estrogen
administration in rats after severe scald injury attenuated the
hypermetabolic losses of body mass [50], which further supports
that the hormonal shift towards estrogens in patients with burn
injury may be an adaptive mechanism of burn trauma, rather than
an association with a poor prognosis.
In evaluation of the data presented it should be noted that only
male patients were enrolled since the estrus cycle in female
patients, which induces fluctuations in circulating adrenal and
gonadal steroids, would have introduced a confounding factor. Fur-
thermore, the time at which blood was sampled from patients,
after admission and inclusion in the study, was not consistent
across the time of day. As both adrenal and gonadal hormones
are known to have a circadian rhythm, this could be considered a
caveat, however, the diurnal pattern has been reported to be
abolished after burn injury [8,36,37], and, hence, was not expected
to affect our findings. Direct comparison between age groups was
not possible because of the age differential between the severely
and moderately injured groups.
While associations between several endogenous steroids and
burn size were identified, as well as a survivor / non-survivor bias
between some steroids, both observations require a larger samplesize for confirmation. Additionally, it should be noted that
reference values from healthy men should be compared with burn
injured patients with caution, as patients with critical illness often
suffer from other pathophysiological differences as well as major
changes in vascular permeability [54]. In turn, vascular leakage
could thus cause variations in total protein, as well as serum
albumin and steroid-binding globulin concentrations, which is
likely to affect the concentration of free and bioavailable steroids.
As albumin is a negative acute-phase reactant protein (ARP) and
immunoglobulins are positive ARP, this could explain the observed
opposite trends of the changes in concentrations of albumin and
total protein. Our study does not aim to explain the causal mecha-
nism for the altered steroid synthesis in burn injury, but does
support a relationship.5. Conclusion
Our data indicate that burn injury alters endogenous steroid
biosynthesis, with decreased testosterone concentrations and
elevated estrone concentrations during the first 21 days after the
injury. Concentrations of plasma cortisol, corticosterone,
11-deoxycortisol, androstenedione, 17OH-progesterone, 17OH-
pregnenolone and pregnenolone were found to correlate with the
area of burn injury. Concentrations of testosterone decreased dur-
ing the acute phase, were up to ten-times lower than the reference
values expected in healthy adult men, and did not recover during
the study period. By day 21 after injury, testosterone concentra-
tions increased in patients of younger age, but not in older patients.
The highest concentrations of estrone were observed on day 3
after injury and then declined by day 21 to concentrations compa-
rable to those observed on the day of injury. No difference in the
concentration of steroids was observed between patients with
severe and moderate burn injury. If the finding of elevated estrone
26 M. Bergquist et al. / Clinical Mass Spectrometry 1 (2016) 19–26concentrations can be confirmed in a larger hypothesis-driven
study, this may have a future therapeutic potential. Further studies
will be needed to delineate the underlying mechanisms behind
alterations in steroid biosynthesis after burn injury.Competing interests
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